Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Read now
Collin Tebo, Maryann Mazer-Amirshahi, Paul Wax, Sharan Campleman, Edward Boyer, Jeffrey Brent, Amit Sheth, Raminta Daniuaityte & Robert Carlson. (2021) Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation. Journal of Psychoactive Drugs 53:3, pages 207-214.
Read now
Read now
Articles from other publishers (3)
Alane Celeste-Villalvir, Cathy Crouch, Laura Witte, Angela M. Heads, Michael Weaver, Joy M. Schmitz, Frances Isbell & Vanessa Schick. (2023) Assessing Stage of Change and Harm Reduction Strategies for Synthetic Cannabinoid Use Among Individuals Experiencing Homelessness in Houston, Texas. Journal of Drug Issues, pages 002204262311612.
Crossref
Crossref
Wafaa M. Abdelmoneim, Nagwa M. Ghandour, Mohamed Fawzy, Marwa Kh. Mohammed, Abdelrahman G. Ramadan & Nora Z. Abdellah. (2022) Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study. Middle East Current Psychiatry 29:1.
Crossref
Crossref
I. Al-Banaa, L. Hawkins, S.L. Hill, D.J. Lupton, G. Jackson, E.A. Sandilands, S.M. Bradberry, J.P. Thompson, S. Rushton & S.H.L. Thomas. (2020) Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis. International Journal of Drug Policy 77, pages 102672.
Crossref
Crossref